EQUINE INFECTIOUS ANEMIA VIRUS ANTIBODY TEST
FUSION PROTEIN ENZYME-LINKED IMMUNOSORBENT ASSAY
(FP-ELISA II)
Manufactured by: Distributed by:
SafePath Laboratories LLC Centaur Inc.
Carlsbad, CA 92010 USA 1351 Old 56 Highway West - Bldg F
US Veterinary License No 430 Olathe, KS 66061
800-236-6180
Fax 913-390-5907
www.centaurunavet.com
SUMMARY AND EXPLANATION
The FP-ELISA II kit utilizes a synthetic antigen from the virus envelope and a core p26 antigen fused into one protein in an enzyme-linked immunosorbent assay (ELISA) for the qualitative determination of antibodies to Equine Infectious Anemia Virus (EIAV) in horse serum. The fusion protein (FP) is coated onto microwells and conjugated to horseradish peroxidase. In field trials, the results of testing by the EIAV antibody test show a high correlation with the agar gel immunodiffusion test of Coggins (1). Because there is no cure and no approved vaccine for EIAV, disease control measures are limited to the identification and isolation of infected animals (2, 3). The FP-ELISA II antibody test provides a rapid and reliable method for the detection of EIAV antibodies.
PRINCIPLES OF THE TEST
In the FP-ELISA II test, the wells of the microplate are coated with the fusion protein which contains amino acid sequences identical to a section of an EIAV envelope protein and a recombinant core antigen. The result is multiple epitopes of EIAV are available to bind antibody present in the serum specimen of an EIAV infected equid.
Serum samples are added to wells followed by addition of the fusion protein conjugated to horseradish peroxidase. Upon completion of a 15 minute incubation period, the well is washed with distilled or deionized water. A single component TMB chromogen (tetramethylbenzidine) is added to the well and incubated at room temperature.
If antibodies are present in the test specimen, color develops in the well. If antibodies are absent, no color or only minimal color develops. Positive and negative control sera are run with each group of serum specimens to provide representative color development.
REAGENTS: All materials are provided ready-to use.
Materials Provided
Materials Required But Not Provided
Optional Materials Not Provided
1. Microplate wash system
PRECAUTIONS
STORAGE AND STABILITY
All materials provided in the test kit should be stored at 2° to 7°C. Unused wells of the microplate should be stored, and re-sealed properly, with the desiccant in the bag provided.
SPECIMEN COLLECTION AND PREPARATION
Horse serum is recommended for use with the FP-ELISA II test kit. Whole blood may be collected by venipuncture and the serum fraction separated by centrifugation for 10 minutes at approximately 2500 rpm. Serum separators may be used. Anticoagulants are not recommended.
Specimens may be stored at refrigerator temperature (2° to 7°C) for five days. If longer storage is needed, specimens should be frozen at -20°C. Repeated freezing and thawing should be avoided. Frozen samples should thaw at room temperature and should be mixed by gentle inversion before testing begins.
ASSAY PROTOCOL
Preliminary Steps
Testing Procedure
of distilled or deionized water. If using an automated washer additional washes may be necessary to remove the Conjugate.
QUALITY CONTROL
The Positive Control Serum produces an intense color in the assay. When read spectrophotometrically with the spectrophotometer blanked on air, the Positive Control Serum should yield an O.D. of 0.3 to 1.5. If color development in the Positive Control Serum is weak or appears to be less than usual to the experienced user, the assay should be repeated. A lack of color development in the Positive Control serum may be due to the use of expired or damaged reagents or wells. The Negative Control Serum produces either no color or only a faint tint. When read spectrophotometrically, the Negative Control Serum should yield an O.D. of 0.0 to 0.100. The presence of color could be due to cross contamination during the test procedure or inadequate washing of the wells.
RESULTS
For visual determination, any test well yielding color development greater than the Negative Control Serum should be considered positive for antibodies to EIAV. Wells which visually show color development equal to or less than the Negative Control Serum should be considered to contain serum specimens which are free of detectable antibody to EIAV.
For spectrophotometric determination, blank the spectrophotometer on air. Add 0.05 OD to the negative control value to establish the test cutoff value. Specimen wells with values above the cutoff should be considered positive for antibodies to EIAV. Specimen wells with values equal to or below the cutoff should be considered negative for antibodies to EIAV. It is recommended that any positive ELISA evaluation be confirmed using the agar gel immunodiffusion (AGID) test. Discrepant samples should be re-evaluated according to State regulations or be sent to the National Veterinary Services Laboratory in Ames, Iowa for confirmation before being reported as positive.
TECHNICAL SERVICES
If you have any questions regarding the use of this test, please call Centaur, Inc. in the USA at 800-236-6180 or outside the US (913) 390-6184.
REFERENCES